REGENERON PHARMACEUTICALS, INC. Treasury Stock, Value
REGENERON PHARMACEUTICALS, INC. (REGN) had Treasury Stock, Value of $9.91 billion as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockValue · last filed 2022-11-03
- 2022-09-30: Treasury Stock, Value $9.91B.
- 2022-06-30: Treasury Stock, Value $9.00B.
- 2022-03-31: Treasury Stock, Value $8.61B.
- 2021-12-31: Treasury Stock, Value $8.26B.
| Period end | Treasury Stock, Value | Treasury Stock, Value as first filed |
|---|---|---|
| 2022-09-30 | $9.91B 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $9.00B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $8.61B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $8.26B 10-Q · filed 2022-11-03 | |
| 2021-09-30 | $7.41B 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $7.22B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $6.94B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $6.61B 10-K · filed 2022-02-07 | |
| 2020-09-30 | $6.24B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $6.14B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.07B 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $739.90M 10-K · filed 2021-02-08 | |
| 2019-09-30 | $488.40M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $441.80M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $444.20M 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $396.40M 10-K · filed 2020-02-07 | |
| 2018-09-30 | $396.37M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $353.85M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $316.24M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $316.20M 10-K · filed 2019-02-07 | $316.24M 10-K · filed 2018-02-08 |
| 2017-09-30 | $316.24M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $316.24M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $316.24M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $316.24M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $316.05M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $316.05M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $307.48M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $306.07M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $288.78M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $287.08M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $181.82M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $169.53M 10-K · filed 2016-02-11 | -$169.53M 10-K · filed 2015-02-12 |
| 2014-09-30 | $43.85M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | -$43.85M 10-Q · filed 2014-08-05 | |
| 2013-12-31 | $0.00 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |